Optimize for the aspects of the supply chain that don't depend on the specific drug. For example, the packaging of pills probably doesn't need to vary that much in general.

But the point isn't that we are prepared for every eventuality (e.g., chloroquine), but that we are doing due diligence in preparing for the likely eventualities (e.g., general purpose respiratory treatments like ventilators).

As a previous commentator noted, the Chinese were providing guidance on chloroquine a month ago.